Concepedia

Mariano Young

MY

Statistics

Publications

7

Citations

359

H-Index

7

Active since

2004

Affiliations

Pfizer (United States)(Current)

National Institutes for Food and Drug Control

Jiangsu Provincial Center for Disease Control and Prevention

East–West Center

Mariano Young is an author at Pfizer (United States) specializing in immunology, conjugate vaccines, and veterinary medicine.

Publications per year

2004–2023

7

Publications

7

Safety, Tolerability, and Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine (PCV20) in Adults 60 to 64 Years of Age

Donald Hurley, Carl Griffin, Mariano Young et al. · Clinical Infectious Diseases · 2020 · 157 citations · Full text

, , +17

A trial to evaluate the safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine in populations of adults ≥65 years of age with different prior pneumococcal vaccination

Kevin Cannon, Charles Elder, Mariano Young et al. · Vaccine · 2021 · 83 citations

, , +16

A comparative study of etanercept plus methotrexate and methotrexate alone in Taiwanese patients with active rheumatoid arthritis: a 12-week, double-blind, randomized, placebo-controlled study.

Joung Liang Lan, Show Jan Chou, Der Yuan Chen et al. · PubMed · 2004 · 54 citations

, , +11

Randomized trial to evaluate the safety, tolerability, and immunogenicity of a booster (third dose) of BNT162b2 COVID-19 vaccine coadministered with 20-valent pneumococcal conjugate vaccine in adults ≥65 years old

David Fitzpatrick, Mariano Young, Kari Yacisin et al. · Vaccine · 2023 · 27 citations · Full text

, , +16

A randomized phase 1 study of the safety and immunogenicity of 2 novel pneumococcal conjugate vaccines in healthy Japanese adults in the United States

David Fitzpatrick, Mariano Young, Daniel A. Scott et al. · Human Vaccines & Immunotherapeutics · 2021 · 15 citations · Full text

, , +17

1–5 of 7